Showing results (181-190 of 217) with videos related to

Sort By:
Pageof 22
Oncogene|October 3, 2002
Significant contribution of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer familiesSophie Gad, Virginie Caux-Moncoutier, Sabine Pagès-Berhouet, et al.
Journal of Genomics|October 14, 2021
Identification of a novel pathogenic variant in PALB2 and BARD1 genes by a multigene sequencing panel in triple negative breast cancer in MoroccoAbdelilah Laraqui, Mathias Cavaillé, Nancy Uhrhammer, et al.
Psycho-Oncology|June 2, 2019
Psychosocial and clinical factors of probands impacting intrafamilial disclosure and uptake of genetic testing among families with BRCA1/2 or MMR gene mutationsNathalie Alegre, Pierre Vande Perre, Yves Jean Bignon, et al.
Science Signaling|September 27, 2018
Manifold roles of β-arrestins in GPCR signaling elucidated with siRNA and CRISPR/Cas9Louis M Luttrell, Jialu Wang, Bianca Plouffe, et al.
Oncotarget|February 7, 2023
The "extreme phenotype approach" applied to male breast cancer allows the identification of rare variants of ATR as potential breast cancer susceptibility allelesMartin Chevarin, Diana Alcantara, Juliette Albuisson, et al.
The Oncologist|March 18, 2015
BRCA1 and BRCA2 mutations in ethnic Lebanese Arab women with high hereditary risk breast cancerNagi S El Saghir, Nathalie K Zgheib, Hussein A Assi, et al.
JAMA|June 7, 2011
Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndromeValérie Bonadona, Bernard Bonaïti, Sylviane Olschwang, et al.
Familial Cancer|November 15, 2011
Uptake of a randomized breast cancer prevention trial comparing letrozole to placebo in BRCA1/2 mutations carriers: the LIBER trialPascal Pujol, Christine Lasset, Pascaline Berthet, et al.
Breast Cancer Research and Treatment|November 14, 2015
Mutation analysis of PALB2 gene in French breast cancer familiesFrancesca Damiola, Inès Schultz, Laure Barjhoux, et al.
Human Mutation|December 9, 2021
Novel germline MET pathogenic variants in French patients with papillary renal cell carcinomas type IMolka Sebai, David Tulasne, Sandrine M Caputo, et al.
Pageof 22